What schedule is lisdexamphetamine (Vyvanse) placed in?

Lisdexamphetamine, commonly known by its brand name Vyvanse, is classified as a Schedule II controlled substance under the Controlled Substances Act. This classification is due to its potential for abuse and dependence. Schedule II substances are recognized for their medical uses but also for having a high potential for abuse, which can lead to severe psychological or physical dependence. Medications in this category often require strict regulations regarding prescription practices.

While there are other schedules like Schedule III, IV, and I, each with varying levels of control and potential for abuse, these classifications do not apply to lisdexamphetamine. Schedule III and IV substances, for instance, have a lower potential for abuse compared to Schedule II substances. Schedule I substances are considered to have no accepted medical use and a high potential for abuse, making them the most restricted.

Understanding these classifications helps in recognizing the regulatory framework surrounding certain medications and the precautions necessary in prescribing and dispensing them, especially those used to treat attention-deficit/hyperactivity disorder (ADHD) like lisdexamphetamine.